TickerFactsScreenerDevelopers

Vaxcyte, Inc. (PCVX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2017: -$29.13M2018: -$57.73M2019: -$106.37M2020: $345.84M2021: $284.02M2022: $953.61M2023: $1.24B2024: $3.31B2025: $2.69B$2.69B
2017Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$2.69B-18.8%
2024$3.31B+166.5%
2023$1.24B+30.1%
2022$953.61M+235.8%
2021$284.02M-17.9%
2020$345.84M+425.1%
2019-$106.37M-84.3%
2018-$57.73M-98.2%
2017-$29.13M—